UBS analyst Brian Meredith lowered the firm’s price target on Travelers (TRV) to $267 from $270 and keeps a Neutral rating on the shares. UBS likes the defensive nature of P&C insurance heading into 1Q25 results, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRV:
- Travelers upgraded to Equal Weight from Underweight at Wells Fargo
- Travelers price target lowered to $274 from $286 at Keefe Bruyette
- Travelers price target raised to $271 from $260 at JPMorgan
- Early notable gainers among liquid option names on February 24th
- Electronic Arts initiated, Workday downgraded: Wall Street’s top analyst calls